Norwalk, Conn. – January 25th, 2019 – BioWave Corp., a health technology company that delivers Smarter Pain Blocking Technology™ today announced a partnership with BetterPT, a mobile platform for physical therapists (PTs) and clinics where patients can discover, schedule and access appointments with PTs or clinics. The partnership will bring BioWave’s newest product, BioWaveGO, to BetterPT’s expansive userbase in order to help patients and their health care providers manage chronic or acute pain.
BioWaveGO is a FDA cleared, over the counter, wearable version of BioWave’s popular non-opioid, pain relief technology. The development of the new BioWaveGO OTC product is the natural evolution of a patented neurostimulator pain relief technology that BioWave has perfected over more than 15 years. BioWaveGO is available in a non-prescription strength to help anyone in acute or chronic pain lead a fuller and active pain-free life. BioWave technology is different than outdated TENS, and has been proven to be not only effective but significantly reduce pain in more than 85% of people who use it, from just one 30-minute treatment.
“We are excited to work with a category leader like BetterPT,” said Brad Siff, President and Founder of BioWave Corporation. “BetterPT, a Global Innovation Partner of Hospital for Special Surgery, has become the premier platform to reach people with chronic or acute pain and is a natural fit to help its users find our BioWave system, which we believe is a life-changing non-opioid, non-addictive, and smarter pain blocking technology.””
BioWave’s FDA-cleared, high frequency neurostimulation technology, described in more detail on its website, delivers soothing therapeutic signals through the skin into deep tissue, blocking pain signals at the source.
“As we further scale our Physical Therapy marketplace, we are pleased to be working with the BioWave team to bring its proven technology to our audience in our mutual goal is to help patients get better” said Greg Peters, Chief Executive Officer, BetterPT .